Ligand Pharmaceuticals Tr Stock Today
Ligand Pharmaceuticals is trading at 0.12 as of the 18th of April 2024; that is No Change since the beginning of the trading day. The stock's open price was 0.12. Equity ratings for Ligand Pharmaceuticals Tr are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Valuation
Check how we calculate scores
Ligand Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ligand Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ligand Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
Ligand Pharmaceuticals Tr [LGNZZ] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ligand Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Ligand Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ligand Pharmaceuticals classifies itself under Other sector and is part of Other industry. The entity has 0 outstanding shares.
Ligand Pharmaceuticals generates negative cash flow from operations
Check Ligand Pharmaceuticals Probability Of Bankruptcy
Ligand Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Ligand Pharmaceuticals jumping above the current price in 90 days from now is about 87.89%. The Ligand Pharmaceuticals Tr probability density function shows the probability of Ligand Pharmaceuticals pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Ligand Pharmaceuticals Tr has a beta of -1.3056. This indicates as returns on its benchmark rise, returns on holding Ligand Pharmaceuticals Tr are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Ligand Pharmaceuticals is expected to outperform its benchmark. Additionally, ligand Pharmaceuticals Tr has an alpha of 0.7709, implying that it can generate a 0.77 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Ligand Pharmaceuticals to move above the current price in 90 days from now is about 87.89 (This Ligand Pharmaceuticals Tr probability density function shows the probability of Ligand Pink Sheet to fall within a particular range of prices over 90 days) .
Ligand Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Ligand Pharmaceuticals market risk premium is the additional return an investor will receive from holding Ligand Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ligand Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Ligand Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Ligand Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.61 | |||
| Semi Deviation | 8.17 | |||
| Standard Deviation | 12.72 | |||
| Variance | 161.83 |
Ligand Stock Against Markets
Picking the right benchmark for Ligand Pharmaceuticals pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ligand Pharmaceuticals pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ligand Pharmaceuticals is critical whether you are bullish or bearish towards Ligand Pharmaceuticals Tr at a given time. Please also check how Ligand Pharmaceuticals' historical prices are related to one of the top price index indicators.
Ligand Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ligand Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Ligand Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ligand Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
How to buy Ligand Pink Sheet?
Before investing in Ligand Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ligand Pharmaceuticals. To buy Ligand Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ligand Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ligand Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ligand Pharmaceuticals Tr stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ligand Pharmaceuticals Tr stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ligand Pharmaceuticals Tr, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Ligand Pharmaceuticals Tr?
The danger of trading Ligand Pharmaceuticals Tr is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ligand Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ligand Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ligand Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Ligand Pharmaceuticals information on this page should be used as a complementary analysis to other Ligand Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Ligand Pink Sheet analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |